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Detection of bacteraemia or fungaemia by blood culture is critical 
in managing patients with infection, and directs the appropriate 
selection of antimicrobials. Blood culture is a common laboratory 
investigation where blood is inoculated into culture medium 
and incubated. Media used in blood culture bottles support the 
growth of most medically important bacteria and fungi, including 
anaerobes, which grow adequately in the aerobic blood culture 
bottle, hence separate anaerobic bottles are infrequently used.1,2 The 
goal of culturing blood is to determine whether a pathogenic micro-
organism(s) is responsible for the patient’s clinical presentation. 
‘False positive’ results occur when a skin commensal(s) rather than 
a true pathogenic organism is grown. Proper cleaning of the skin is 
a vital component of venesection to reduce the false-positive rate, 
yet poor technique is common when collecting blood for culture. 
This lapse results in inappropriate use of antibiotics, increased 
antibiotic resistance and prolonged hospital stay. A further barrier 
to correct laboratory interpretation of blood culture results is 
inadequate relevant clinical details on the accompanying request 
form. These guidelines contextualise the place of blood cultures in 
the management of sepsis and detail the appropriate method for 
acquiring blood for culture, to reduce the false-positive rate.
Methods
We performed a literature review of the diagnosis and management 
of sepsis; identified a number of international best practice standards, 
including recommendations of the United Kingdom Department of 
Health, International Sepsis Forum, Society of Critical Care Medicine, 
Surgical Infection Society, American Association of Critical Care 
Nurses, American Association of Chest Physicians, American College 
of Emergency Physicians, American Thoracic Society, Australian and 
New Zealand Intensive Care Society, European Society of Intensive 
Care Medicine, Indian Society of Critical Care Medicine, European 
Respiratory Society, Infectious Diseases Society of America, and the 
Clinical and Laboratory Standards Institute; and studied consensus 
expert opinion documents.
Definitions
Blood culture. Collection and inoculation of blood into culture 
medium with the aim of growing pathogenic bacteria or fungi for 
diagnostic purposes.
Bacteraemia. The presence of viable bacteria in the bloodstream 
which may be transient (e.g. following dental procedures), intermittent 
(e.g. undrained abscesses), or continuous (e.g. endovascular 
infection).
Fungaemia. The presence of viable fungi in the bloodstream.
Infection. An inflammatory response to one or more micro-
organisms, or the invasion of normally sterile sites by those 
organisms.
Systemic inflammatory response syndrome (SIRS). A 
consequence of the host inflammatory response that can follow 
infection or other injury, defined as the clinical cluster of two or 
more of:
•   temperature >380C or <360C
•   heart rate >90 beats/minute
•    respiratory rate >20 breaths/minute or paCO2 <4.3 kPa (32 
mmHg)
•    white cell count >12 000 cells/mm3, <4 000 cells/mm3, or >10% 
immature white blood cells (band forms).3
Sepsis. SIRS resulting from documented infection.3,4
Severe sepsis. Documented sepsis associated with organ 
dysfunction, hypoperfusion or hypotension. Perfusion abnormalities 
may manifest as, but are not limited to:
•   lactic acidosis
•   oliguria
•   acute alteration in mental state
•   areas of mottled skin
•   capillary refilling requiring ≥3 seconds
•   disseminated intravascular coagulation
•    acute lung injury or acute respiratory distress syndrome 
(ARDS)
•    cardiac dysfunction, as defined by echocardiography or direct 
measurement of the cardiac index.3,5
Septic shock. The presence of severe sepsis plus one or both of 
the following:
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The incidence of sepsis is increasing globally, with high morbidity 
and mortality. Prompt, accurate detection of bacteraemia and 
fungaemia is imperative for improving patient care, yet health care 
professionals lack training in correct blood culture techniques. 
These guidelines discuss the clinical importance of blood cultures, 
the indications for their use and the correct technique for optimal 
yield of pathogenic micro-organisms that cause sepsis.
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•    systemic mean blood pressure <60 mmHg (or <80 mmHg if 
the patient has baseline hypertension) despite adequate fluid 
resuscitation
•    maintaining systemic mean blood pressure >60 mmHg (or 
>80 mmHg if the patient has baseline hypertension) requires 
support with inotropic/vasoactive agents.3,4
Multi-organ dysfunction/failure. Multi-organ failure is often 
a consequence of severe sepsis and septic shock, and refers to the 
presence of altered function affecting more than one organ in an 
acutely ill patient such that homeostasis cannot be maintained without 
intervention. Multiple organ dysfunction syndrome (MODS) is either 
primary (directly attributable to a well-defined insult) or secondary 
(as a consequence of the host response). MODS is characterised by, 
but not limited to, abnormalities in serum creatinine, platelet count, 
serum bilirubin, Glasgow coma score, pressure adjusted heart rate, 
and arterial oxygenation.3,5
Sepsis and the significance of blood 
culture
Some 1.8 million cases of sepsis occur worldwide each year;6 however, 
owing to variable definitions and reporting, this is probably an 
underestimate. A more accurate estimate may be as high as 18 million, 
an incidence of 3/1 000 population.7 Sepsis is the most common cause 
of death in non-coronary intensive care units worldwide.8,9 The 
mortality rate from sepsis is generally between 30% and 70%, and 
is higher in persons with a pre-existing disease.3,8 Elderly, critically 
ill and immunocompromised persons are particularly vulnerable.10 
Population-based studies of incidence and prevalence of sepsis in 
South Africa have not been undertaken.
There are several reviews of the pathophysiology of sepsis.11-16 The 
direct effects of invading micro-organisms, their toxic products, or 
both, may contribute to pathogenesis of sepsis. Important factors 
include endotoxin, bacterial cell wall components (peptidoglycan, 
muramyl dipeptide, and lipoteichoic acid), and bacterial products 
such as staphylococcal enterotoxin B, toxic shock syndrome toxin-1, 
pseudomonas exotoxin A, and M protein of haemolytic group A 
streptococci.17 Cellular injury and organ dysfunction occur as a 
consequence of ischaemia,18 cytopathic injury19 and increased rate 
of apoptosis.20 Panendothelial activation in sepsis also leads to 
widespread tissue oedema, endothelial dysfunction, hypotension, 
upregulation of adhesion molecules, and impaired anticoagulant 
properties leading to MODS.21
Blood culture plays an integral role in the evaluation of sepsis.22 As 
bacteraemia is often associated with fever, clinicians are encouraged 
to obtain blood samples for culture from febrile patients.23 The 
indications for blood culture are broad and ill-defined.24 Other 
than pyrexia, clinical parameters alone are unhelpful in predicting 
bacteraemia and cannot be used in isolation to determine the timing 
of blood sampling for culture.25
Clinical features of sepsis
The clinical features of sepsis relate to the causative organism, 
the involved site, severity, and the host response to infection. 
Symptoms and signs of sepsis are usually superimposed on the 
patient’s underlying illness and primary infection. Hence, their rate 
of development and clinical presentation varies. Common clinical 
features of sepsis include lethargy, fever (although hypothermia may 
occur) and an elevated or reduced white blood cell count.26 Sweating, 
rigors, tachycardia, hypotension, tachypnoea, warm peripheries, 
confusion, oliguria and jaundice may also occur (Table I).
Diagnosis of sepsis
Sepsis is primarily a clinical diagnosis, supported by laboratory 
investigation and imaging. Culture of specimens from a sterile site 
is the gold standard microbiological investigation and the key to 
successful diagnosis.27,28 Occasionally, serology may aid diagnosis. 
Culture is a slow process compared with rapid molecular diagnostic 
tests that detect genetic material and can be used at the ‘point-of-
care’.29 A point-of-care test for sepsis would be an extremely useful 
addition to the diagnostic armory.
The indications for blood culture are shown in Table II. Although 
only 5 - 15% of blood cultures drawn in febrile patients are positive, 
approximately half of all patients with severe sepsis demonstrate 
bacteraemia at the time of diagnosis.30 The presence or absence of 
a positive blood culture does not appear to influence outcome of 
sepsis, suggesting that prognosis is more related to severity of sepsis.31 
Hospital-acquired infections (HAI) diagnosed from blood culture 
have a higher mortality than those acquired in the community.32
Table I. Clinical and laboratory manifestations of sepsis
Symptoms Signs Laboratory findings
Rigors Temperature increase or decrease Leucocytosis or leucopenia
Sweating Tachycardia Hypoalbuminaemia
Nausea and vomiting Hypotension Increased INR, increased APTT, decreased 
platelets, DIC
Symptoms related to affected organ system 
(e.g. cough, diarrhoea, dysuria, etc.)
Tachypnoea, hyperventilation (acute lung 
injury)
Hyperglycaemia
Warm pink peripheries Hyperlactataemia
Confusion Increasingly negative base excess
Oliguria Elevated CRP, ESR,* procalcitonin, fibrinogen
Jaundice
Haemorrhagic lesions, cutaneous bullae, 
cellulitis
*ESR should not be used in patients with HIV, as hypergammaglobulinaemia and immune hyperactivation commonly leads to an increased ESR in the absence of sepsis.
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Principles of sample collection for blood 
culture
1.    Blood cultures should be drawn when there is a clinical suspicion 
of bloodstream infection.33
2.    Blood should not be collected from indwelling arterial or venous 
lines unless an infected intravenous line is suspected.34 Should 
blood be drawn for culture from an indwelling line, a second 
specimen should be obtained from a peripheral site.
3.    Two or more blood specimens should be collected using sterile 
technique at separate sites, before administering antibiotics.35-37 
Except in very unusual cases, no more than 3 sets of blood 
cultures should be collected in one 24-hour period. If all 4 sets 
are negative after 24 hours and sepsis is still suspected, more 
cultures may be collected.38 A larger number of cultures may have 
to be collected from persons already receiving antimicrobials39 
although, if clinical condition allows, stopping antibiotics and 
re-culturing after 48 hours is preferred.
4.    Ideally, a minimum of 10 ml of blood, depending on the blood 
culture system used, should be inoculated into a culture bottle 
when taking blood from adults.40 Adequate volumes of blood 
improve detection of pathogenic organisms and reduce time to 
detection.
5.    Arterial blood culture provides no advantage over venous 
samples.41
6.    Changing needles between venepuncture and inoculation 
into culture bottles is controversial. Discontinuing this practice 
owing to lack of evidence that it decreases contamination and 
the increased risk of sharp injuries has been recommended.42,43 
However, a meta-analysis challenges this recommendation, 
suggesting a slight overall benefit of switching needles.44 Until 
more definitive studies are available, we recommend that the 
risk of changing needles after venepuncture does not outweigh 
the benefit. More important ways to decrease contamination 
of blood culture bottles include the use of tincture of iodine as 
a disinfectant,45 avoidance of drawing blood through existing 
intravenous lines34 and disinfecting the membrane of the blood 
culture bottle.46
7.    It is a medico-legal requirement that the patient’s notes must always 
document acquiring blood for culture, including indication, site, 
time of taking blood culture and a legible name.
Table III details recommendations for how to correctly send blood 
to the laboratory for culture.
Optimal number of blood cultures
The optimal number of blood cultures that should be obtained in a 
febrile patient varies according to the suspected diagnosis or clinical 
condition, the suspicion of underlying infection, and the urgency of 
the need for treatment.47
•    One blood culture is rarely, if ever, sufficient or advisable.21 A 
positive result on a single culture is difficult to interpret, unless 
an unequivocal pathogen is isolated.
•    Two blood cultures are usually adequate when continuous 
bacteraemia is anticipated.48
•    Three blood cultures are reasonable when intermittent 
bacteraemia is suspected.49
We believe that more than 3 blood cultures is rarely justifiable in 
a resource-limited setting. Furthermore, the probability of obtaining 
a false-positive result increases steadily as more blood cultures are 
performed.
Timing of blood cultures
Few systematic studies have been conducted on the timing of blood 
cultures and the optimal interval between successive tests.38 The 
ideal is to collect blood at time intervals ranging from one to several 
hours.50 However, it is sufficient and appropriate to obtain blood from 
2 separate sites within minutes of each other from patients who are 
acutely ill or those in whom the likelihood of continuous bacteraemia 
is high.51 By contrast, in patients suspected to have intermittent 
bacteraemia, it is advisable to obtain multiple blood cultures 6 - 36 
hours apart.38,52 One study showed no difference in yield whether 
blood samples for cultures performed within a 24-hour period were 
drawn simultaneously or at spaced intervals.53 Antibiotics should not 
be withheld in sick patients apart from a reasonable delay to collect 
more than 1 culture sample.
Volume of blood to be taken for culture
A minimum of 10 ml (and preferably 20 ml) of blood should be 
obtained from adults,38,41,53,54 and 1 - 5 ml (and preferably more) from 
infants and children.40,55,56 The yield from blood culture depends 
upon the volume of blood cultured,57-59 the yield in adults increasing 
approximately 3% per ml of blood cultured.
Maintaining the correct ratio of blood to culture medium is 
important. Most blood culture bottles contain the anticoagulant 
sodium polyanetholsulphonate (SPS). SPS can inactivate lysozyme, 
some antibiotics, and parts of the complement cascade. However, SPS 
can also be toxic to certain fastidious organisms. Adding sufficient 
blood to the bottle helps negate this latter effect. A dilution of blood 
in broth by a ratio of 1:5 has been recommended.60,61
Type of blood culture bottle
Most blood culture systems are now automated, with some form of 
continuous monitoring to detect growth. The bottles contain broth 
supplemented with additives. Different bottles are designed either to 
be used in different patient groups, or to isolate different classes of 
pathogens. A few general principles apply:
•    Standard aerobic bottles are suitable for the recovery of most 
common bacterial pathogens, including aerobes and facultative 
anaerobes. These are not as suitable for supporting the growth of 
strict anaerobes, and therefore traditional advice has been to use 
a paired set of aerobic and anaerobic bottles when taking blood 
cultures.62 The routine use of anaerobic bottles has been questioned, 
as the incidence of anaerobic bacteraemia is decreasing61,63,64 and 
most infections involving anaerobes are clinically suspected and 
appropriate empiric therapy is administered before blood culture 
results become available.65,66 Conversely, improved yield of micro-
organisms when using aerobic-anaerobic paired blood cultures has 
been demonstrated.67,68 Although firm evidence is unavailable, we 
believe that the routine use of anaerobic bottles is not warranted, 
particularly in resource-limited settings.
•    Some manufacturers produce aerobic and anaerobic bottles with 
Table II. Indications for blood culture
1. Clinical features of sepsis including tachycardia, 
tachypnoea, increased or sub-normal temperature and 
change in sensorium, hypotension or prostration
2. Suspicion of infective endocarditis
3. Pyrexia of unknown origin
4. Unexplained leucocytosis or leucopenia
5. Systemic and localised infections including suspected 
meningitis, osteomyelitis, septic arthritis, acute untreated 
bacterial pneumonia or other possible bacterial infection
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additives (such as charcoal or resins) that inactivate antibiotics. 
These are preferable when taking blood cultures from patients 
already on antimicrobials, but are more expensive. There is 
evidence that the average time to positivity with these bottles is 
shorter than with normal aerobic and anaerobic bottles; however, 
their cost-effectiveness is unclear.61 Paediatric bottles are often 
supplemented with growth factors and usually have additives 
which will bind antibiotics, allowing improved recovery of bacteria. 
Together with the lower concentration of SPS, these features allow 
smaller volumes of blood to be inoculated.60,61
•    Mycobacterial blood culture bottles contain broth suitable for 
the isolation of mycobacteria and are valuable for the detection 
of disseminated mycobacterial infections, both M. tuberculosis 
and non-tuberculous mycobacteria. However, these bottles are 
often also used to enhance the recovery of yeasts from blood, 
although there is less evidence to justify this practice.69,70 Given the 
additional expense, routine blood culture bottles should be used 
for detection of candidaemia, and mycobacterial blood cultures 
should be reserved for suspected mycobacterial infections.71
Conclusion
Blood culture remains one of the most important microbiological 
tests available to the clinician. Members of the healthcare team 
who perform blood cultures must have a sound comprehension of 
the principles that underlie this important diagnostic tool. These 
guidelines provide practical and accessible guidance for medical 
students, nurses and doctors on the correct performance of blood 
collection for culture and should be applicable to all levels of healthcare 
in South Africa. Adoption of these guidelines and implementation of 
procedures to improve the quality of blood culture investigations 
will reduce the risk of blood sample contamination and improve the 
management and care of patients with sepsis.
These guidelines are endorsed by the South African Society for 
Clinical Microbiology (SASCM).
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Table III. Procedure for blood culture
Step Procedure
1 Verify the patient’s identity: Ask the patient for his or her name. Check the armband. Look on wall above the bed or in the patient 
notes to confirm identity.
2 Inform the patient of your intentions and explain the procedure. Always obtain verbal consent.
3 Assemble the correct materials required for blood culture:
•   blood culture bottle(s)
•   syringe (10 ml or more)
•   needle (22 gauge or more)
•   sterile gloves
•   tourniquet
•   adhesive strip
•    povidone iodine or alcohol solution (or other suitable skin disinfectant)
•    sterile pack containing cotton/gauze swabs, sterile paper x2 and waste bag
•   patient labels
•   sharps waste disposal bin.
4 Open the sterile blood culture pack onto the trolley. Remove the sterile sheet and place under the patient’s arm. Pour povidone iodine 
or alcohol solution into fluid recess located on blood culture tray/pack. Drop needle and syringe onto sterile field.
5 Apply tourniquet and select a suitable vein. Wash hands with soap and water or disinfect with alcohol hand disinfectant. Dry your 
hands or rub the hand disinfectant in until dry. Apply sterile gloves.
6 Clean the puncture site with povidone or alcohol solution using aseptic technique. Allow 1 - 2 minutes for the disinfectant to dry. 
Place green sterile cover with opening over site for blood culture.
7 Carefully insert needle into patient’s blood vessel and collect a minimum of 10 ml of blood (adults). If using the vacutainer system, 
the blood culture must be the first blood specimen to be collected.
8 Release tourniquet. Remove needle and syringe from puncture site. Place dry swab on puncture site and apply pressure. If blood has 
not been collected directly into the blood culture bottle with the vacutainer system, inoculate blood into culture bottle, having first 
disinfected the top of the blood culture bottle with an alcohol swab (a webcol is adequate).50 If blood is being collected for other tests, 
always inoculate blood culture bottle first. Do not change needles between blood sample collection and inoculation of blood culture 
bottle.
9 Gently rotate the blood culture bottle to mix the blood and culture medium (do not shake vigorously).
10 Label the blood culture bottle, making sure not to remove the ‘tear-off ’ label on the bottle. Make sure that patient labels do not cover 
the blood culture bottle bar code label and are not stuck across the bottom of the blood culture bottle. Complete a laboratory request 
form. Remember to include the site, date and time of collection, full clinical information regarding the suspected diagnosis, and 
contact details for the clinician responsible for the patient.
11 Deliver the blood culture bottle to the laboratory as soon as possible. If there is a delay in getting the sample to the laboratory, do not 
refrigerate the bottle; rather leave it at room temperature.
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